logo
menu
← Return to the newsfeed...

Gevo announces pricing of public offering of common stock and warrants

Gevo, a renewable chemicals and next-generation biofuels company, has priced its underwritten public offering of common stock units.

The company announced that it has agreed to sell 4,300,000 common stock units. Each common stock unit consists of one share of common stock and one-tenth of a Series C warrant to purchase one share of common stock at a public offering price of $4.00 per common stock unit. The warrants will have an exercise price of $5.50 per share, be exercisable from the date of original issuance and will expire on 19 May 2020. The shares of common stock and the warrants will be immediately separable and will be issued separately. The gross proceeds to Gevo from this offering are expected to be approximately $17.2 million not including any future proceeds from the exercise of the warrants.

Gevo currently intends to use the net proceeds from the offering, excluding any future proceeds from the exercise of the warrants, to fund working capital and for other general corporate purposes.

In connection with the offering, Cowen and Company is acting as sole manager.

The offering of common stock units was made pursuant to Gevo's shelf registration statement filed with the Securities and Exchange Commission (SEC) and declared effective, and is expected to close on or about 19 May 2015, subject to customary closing conditions. This press release does not constitute an offer to sell, or the solicitation of an offer to buy, these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted.

A preliminary prospectus supplement describing the terms of the offering has been filed with the SEC and a final prospectus supplement will be filed with the SEC.





224 queries in 0.570 seconds.